MYM Nutraceuticals Signs Letter of Intent To Acquire Crop Infrastructure Corp

MYM Nutraceuticals (CSE: MYM) this morning announced that it has signed a letter of intent to acquire Crop Infrastructure Corp (CSE: CROP). The transaction is set to be an all share transaction with Crop Corp shareholders receiving one share of MYM for every 10.5 shares held of Crop.

MYM Nutraceuticals Logo

Little was provided in terms of transactional details, with no timeline for the close of the proposed transaction provided. MYM identified however that it intends to conduct an extensive restructuring plan for Crop Corp, who has had notable funding and execution issues as of late. The firm recently lost the majority of its Nevada hemp crop due to weed infestations, and a herd of antelope that made the field home.

That Nevada property also included a harvest that MYM and Crop had conducted a joint venture on. The resulting loss forced Crop to issue a guarantee that MYM would receive its initial funding back at a minimum. If this wasn’t enough, Crop Corp is also currently in default on its Nevada THC Property as well as secured debt, of which the status is currently unclear.

While Crop Corp has sizable investments in associates, the manner of ownership results in the firm having no revenues to record as of yet. Its currently in the process of calling certain debts owed by associates as a means of satisfying certain debts.

MYM’s team has proven to be extremely knowledgeable and reliable in helping Crop realign our strategy. They are extremely talented and well capitalized. We believe that this transaction is in the best interest of our shareholders.

Michael Yorke, CEO of Crop

The announcement of the proposed acquisition is stated to be one of the first opportunities that a pivoted MYM will conduct. The firm concurrently announced that it is pivoting its business strategy to provide “integrated strategic, financial, management, operational and marketing services to cannabis entities that have valuable assets but require management support and capital to navigate today’s challenging landscape.”

The letter of intent is non-binding. If executed, it will result in Crop Corp shareholders receiving an estimated 19,073,874 shares of MYM Nutraceuticals based on data provided by the CSE.

Based on MYM Nutraceuticals’ closing price yesterday of $0.245, the transaction values Crop Infrastructure Corp shares at approximately $0.0233 per share.


Information for this briefing was found via Sedar, MYM Nutraceuticals and Crop Infrastructure Corp. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold and Silver May Be Ready for Another Run | Shawn Khunkhun – Contango Silver & Gold

Silver Is Strong Again, and This Producer Is Ramping Up | Arturo Prestamo – Santacruz Silver

Gold Giant Agnico Eagle Makes a Critical Minerals Bet | Avenir Minerals x Fox River

Recommended

Altamira Gold Extends Maria Bonita Porphyry System Westward With 70.6 Metres At 0.51 g/t Hit

Antimony Resources Reports 13.9% Antimony in Latest Drill Core at Bald Hill

Related News

MYM Nutraceuticals Commences Planting at Nevada Joint Venture

MYM Nutraceuticals Inc. (CSE: MYM) announced yesterday that they and their joint venture partner, Elite...

Friday, June 14, 2019, 07:00:24 AM

MYM Nutraceuticals Soars in Intraday Trading

MYM Nutraceuticals (CSE: MYM) took investors for a wild ride today, with the equity soaring...

Monday, October 28, 2019, 03:53:48 PM

Crop Corp In Default on Nevada THC Property, Secured Debt

Crop Infrastructure Corp (CSE: CROP) halted equity trading this morning prior to putting out a...

Friday, October 11, 2019, 11:25:43 AM

MYM Nutraceuticals Terminates LOI To Acquire Crop Corp

Crop Infrastructure Corp (CSE: CROP) and MYM Nutraceuticals (CSE: MYM) have ended their short lived...

Tuesday, November 26, 2019, 10:07:58 AM

MYM Nutraceuticals Posts No Q1 Revenues, Spends $1.45 Million on Advertising

MYM Nutraceuticals (CSE: MYM) filed its first quarter 2020 financials this afternoon, indicating that it...

Wednesday, October 30, 2019, 01:37:19 PM